Dr. Matthew J Krasin, MD

Claim this profile

St.Jude Children's Research Hospital

Studies Rhabdomyosarcoma
Studies Soft Tissue Sarcoma
3 reported clinical trials
8 drugs studied

Area of expertise

1Rhabdomyosarcoma
Matthew J Krasin, MD has run 2 trials for Rhabdomyosarcoma. Some of their research focus areas include:
Stage IV
Stage II
Stage I
2Soft Tissue Sarcoma
Matthew J Krasin, MD has run 1 trial for Soft Tissue Sarcoma. Some of their research focus areas include:
Stage IV

Affiliated Hospitals

Image of trial facility.
St Jude Children's Research Hospital

Clinical Trials Matthew J Krasin, MD is currently running

Image of trial facility.

Proton Beam Radiation

for Wilms Tumor

Participants are being asked to take part in this clinical trial, a type of research study, because the participants have a Wilms Tumor cancer. Primary Objectives To determine whether delivery of proton beam radiation to a conformal reduced target volume in the flank allows normal flank growth compared to the contralateral untreated side and non-irradiated patients. Secondary Objectives To deliver proton beam radiation to a conformal reduced target volume (partial kidney proton beam radiation therapy) in the affected kidney(s) for patients with Stage V (bilateral Wilms tumor) and specific involved surgical margins yielding no reduction in the high control rates seen with more traditional flank / whole kidney fields. Exploratory Objectives * Study the feasibility of sparing the residual kidney, spine and liver in patients requiring whole abdomen radiation therapy using either a proton beam treatment technique or intensity-modulated radiation therapy ( IMRT) photon based technique. * Study the feasibility of delivering whole lung radiation therapy with proton beams with the goals of sparing the developing breast tissue, heart structures, thyroid and liver. * Develop simultaneous xenografts and organoid models from the same starting material to study Wilms tumor biology and compare responses to chemotherapeutic agents. * Define the evolution of organ specific (kidney, liver, pancreas, etc.) abnormalities (laboratory studies) as an early marker of possible late end organ damage and their relationship to radiation. * Study and evaluate impact of proton therapy on the musculoskeletal system and physical performance and compare with photon therapy cases treated with classical treatment fields. * Assess CTC-AE and Pediatric Patient Reported Outcomes during radiation and in follow-up, correlating with disease, treatment and patient variables. * Correlate quantitative MRI values, including apparent diffusion coefficient (ADC) values, with histopathology findings post-surgery in children with (bilateral) Wilms. * Assess daily variations in proton range along each treatment beam using standard pre-treatment cone beam CT or on-treatment MR.
Recruiting1 award Phase 210 criteria

More about Matthew J Krasin, MD

Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Matthew J Krasin, MD has experience with
  • Image-guided Radiotherapy
  • Bevacizumab
  • Cyclophosphamide
  • Dactinomycin
  • Proton Beam Radiation
  • Surgical Resection
Breakdown of trials Matthew J Krasin, MD has run
Peripheral Neuroectodermal Tumor
Musculoskeletal Tumors

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew J Krasin, MD specialize in?
Matthew J Krasin, MD focuses on Rhabdomyosarcoma and Soft Tissue Sarcoma. In particular, much of their work with Rhabdomyosarcoma has involved Stage IV patients, or patients who are Stage II.
Is Matthew J Krasin, MD currently recruiting for clinical trials?
Yes, Matthew J Krasin, MD is currently recruiting for 1 clinical trial in Memphis Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Matthew J Krasin, MD has studied deeply?
Yes, Matthew J Krasin, MD has studied treatments such as Image-guided radiotherapy, Bevacizumab, Cyclophosphamide.
What is the best way to schedule an appointment with Matthew J Krasin, MD?
Apply for one of the trials that Matthew J Krasin, MD is conducting.
What is the office address of Matthew J Krasin, MD?
The office of Matthew J Krasin, MD is located at: St.Jude Children's Research Hospital, Memphis, Tennessee 38105 United States. This is the address for their practice at the St.Jude Children's Research Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.